e 6080 has been researched along with Asthma in 3 studies
*Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akutsu, I; Fukuda, T; Makino, S; Motojima, S; Numao, T; Toda, M | 1 |
Chand, N; Harrison, JE; Sofia, RD | 1 |
Abe, S; Katayama, K; Katayama, S; Sakuma, Y; Tsunoda, H; Yamatsu, I | 1 |
3 other study(ies) available for e 6080 and Asthma
Article | Year |
---|---|
Inhibition of leukotriene C4 and B4 release by human eosinophils with the new 5-lipoxygenase inhibitor 6-hydroxy-2(4-sulfamoylbenzylamino)-4,5,7-trimethylbenzothiazo le hydrochloride.
Topics: Asthma; Calcimycin; Dose-Response Relationship, Drug; Eosinophils; Humans; In Vitro Techniques; Ionophores; Leukotriene B4; Leukotriene C4; Lipoxygenase Inhibitors; Platelet Activating Factor; Thiazoles | 1995 |
Effect of PAF-antagonists on aeroallergen-induced bronchial eosinophilia in guinea pigs: a therapeutic approach.
Topics: Administration, Oral; Allergens; Animals; Asthma; Atmosphere Exposure Chambers; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Eosinophilia; Guinea Pigs; Lipoxygenase Inhibitors; Male; Platelet Activating Factor; Thiazoles | 1994 |
Inhibition of IgE-mediated leukotriene generation and bronchoconstriction in primates with a new 5-lipoxygenase inhibitor, E6080.
Topics: Animals; Antigens; Ascaris suum; Asthma; Bronchoconstriction; Dose-Response Relationship, Immunologic; Female; Hypersensitivity; Immunoglobulin E; In Vitro Techniques; Lipoxygenase Inhibitors; Lung; Macaca mulatta; Skin Tests; SRS-A; Thiazoles | 1993 |